ELDERLY PATIENTS (60-75 YEARS)

Clinical trials for ELDERLY PATIENTS (60-75 YEARS) explained in plain language.

Never miss a new study

Get alerted when new ELDERLY PATIENTS (60-75 YEARS) trials appear

Sign up with your email to follow new studies for ELDERLY PATIENTS (60-75 YEARS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Major trial aims to boost remission rates for seniors with aggressive blood cancer

Disease control Not yet recruiting

This large Phase 3 trial will test whether adding a third drug (homoharringtonine) to a standard two-drug leukemia treatment works better for older adults. It will enroll 308 newly diagnosed patients aged 60-75 with acute myeloid leukemia (AML). The main goal is to see if the thr…

Matched conditions: ELDERLY PATIENTS (60-75 YEARS)

Phase: PHASE3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

ELDERLY PATIENTS (60-75 YEARS)

Get alerted when new ELDERLY PATIENTS (60-75 YEARS) trials appear

Major trial aims to boost remission rates for seniors with aggressive blood cancer